The DOI matches its Crossref record; 86 of the 86 references it cites were found in a registry or an index.
History of Antibiotics. From Salvarsan to Cephalosporins
Abstract
Infections have represented for a long time the leading cause of death in humans. During the 19th century, pneumonia, tuberculosis, diarrhea and diphtheria were considered the main causes of death in children and adults. Only in the late 19th century did it become possible to correlate the existence of microscopic pathogens with the development of various diseases. Within a few years the introduction of antiseptic procedures had begun to reduce mortality due to postsurgical infections. Sanitation and hygiene played a significant role in the reduction of the mortality due to several infectious diseases. The introduction of the first compounds with antimicrobial activity succeeded in conquering many diseases. In this review we analyzed, from a historical perspective, the development of antibiotics and the circumstances that led to their discovery. The first compound with antimicrobial activity was introduced in 1911 by Erlich. He focused his research activity on the discovery of a "magic bullet" to treat syphilis. Afterwards, Foley and colleagues brought penicillin to the forefront. Streptomycin represents the first drug discovered for the treatment of tuberculosis, and its development included the first use of clinical trials. Finally, with the development of cephalosporins, the introduction of new antimicrobial compounds with broad activity against gram-positive and also some gram-negative bacteria began.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Staphylococcus aureus Infections
Lowy, F. D. (1998) · New England Journal of Medicine · doi:10.1056/nejm199808203390806 · Cited by 6,005
Extended-Spectrum β-Lactamases: a Clinical Update
Paterson, D. L., & Bonomo, R. A. (2005) · Clinical Microbiology Reviews · doi:10.1128/cmr.18.4.657-686.2005 · Cited by 3,491
Prevention of perinatal group B streptococcal disease--revised guidelines from CDC, 2010.
Schrag, S. D., Gorwitz, R. J., Fultz-Butts, K., & Schuchat, A. (2002) · PubMed · Cited by 3,349
Methicillin-Resistant S. aureus Infections among Patients in the Emergency Department
Moran, G. J., Krishnadasan, A., Gorwitz, R. J., Fosheim, G. E., McDougal, L. K., Carey, R. B., & Talan, D. A. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa055356 · Cited by 2,285
Sexually transmitted disease surveillance
O'Connor, B. H., Tillett, H., Berrie, J. R. H., Emslie, J. A. N., & Adler, M. W. (1982) · BMJ · doi:10.1136/bmj.284.6318.825-d · Cited by 2,185
Sexually transmitted diseases treatment guidelines
Burstein, G. R., & Workowski, K. A. (2003) · Current Opinion in Pediatrics · doi:10.1097/00008480-200308000-00006 · Cited by 2,072
Centers for Disease Control and Prevention Sexually Transmitted Diseases Treatment Guidelines
Workowski, K. A., & Berman, S. M. (2007) · Clinical Infectious Diseases · doi:10.1086/511430 · Cited by 1,973
(2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.167.4.603 · Cited by 1,944
An Enzyme from Bacteria able to Destroy Penicillin
ABRAHAM, E. P., & CHAIN, E. (1940) · Nature · doi:10.1038/146837a0 · Cited by 1,333
Schatz, A., Bugle, E., & Waksman, S. A. (1944) · Experimental Biology and Medicine · doi:10.3181/00379727-55-14461 · Cited by 1,150
On a remarkable bacteriolytic element found in tissues and secretions
Fleming, A. (1922) · Proceedings of the Royal Society of London. Series B, Containing Papers of a Biological Character · doi:10.1098/rspb.1922.0023 · Cited by 1,148
Gold, H. S., & Moellering, R. C. (1996) · New England Journal of Medicine · doi:10.1056/nejm199611073351907 · Cited by 1,070
Meta-analysis of the relationship between Helicobacter pylori seropositivity and gastric cancer
Huang, J.-Q., Sridhar, S., Chen, Y., & Hunt, R. H. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70422-6 · Cited by 957
Increasing Prevalence of Multidrug-Resistant Streptococcus pneumoniae in the United States
Whitney, C. G., Farley, M. M., Hadler, J., Harrison, L. H., Lexau, C., Reingold, A., Lefkowitz, L., Cieslak, P. R., Cetron, M., Zell, E. R., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200012283432603 · Cited by 888
Trends in Infectious Disease Mortality in the United States During the 20th Century
Armstrong, G. L. (1999) · JAMA · doi:10.1001/jama.281.1.61 · Cited by 875
Further Observations on Penicillin
Abraham, E. P., Chain, E., Fletcher, C. M., Gardner, A. D., Heatley, N. G., Jennings, M. A., & Florey, H. W. (1941) · The Lancet · doi:10.1016/s0140-6736(00)72122-2 · Cited by 821
Methicillin-resistant staphylococci
Barber, M. (1961) · Journal of Clinical Pathology · doi:10.1136/jcp.14.4.385 · Cited by 729
Spinks, A., Glasziou, P. P., & Del Mar, C. B. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000023.pub4 · Cited by 693
Mulligan, M. E., Murray-Leisure, K. A., Ribner, B. S., Standiford, H. C., John, J. F., Korvick, J. A., Kauffman, C. A., & Yu, V. L. (1993) · The American Journal of Medicine · doi:10.1016/0002-9343(93)90063-u · Cited by 641
BLAND, E. F., & JONES, D. (1951) · Circulation · doi:10.1161/01.cir.4.6.836 · Cited by 620
Penicillin as a Chemotherapeutic Agent
Chain, E., Florey, H. W., Gardner, A. D., Heatley, N. G., Jennings, M. A., Orr-Ewing, J., & Sanders, A. G. (1940) · The Lancet · doi:10.1016/s0140-6736(01)08728-1 · Cited by 603
DOWELL, S. F., BUTLER, J. C., GIEBINK, G. S., JACOBS, M. R., JERNIGAN, D., MUSHER, D. M., RAKOWSKY, A., & SCHWARTZ, B. (1999) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-199901000-00002 · Cited by 505
Resistance to Trimethoprim-Sulfamethoxazole
Eliopoulos, G. M., & Huovinen, P. (2001) · Clinical Infectious Diseases · doi:10.1086/320532 · Cited by 500
Hypertension and hyperuricaemia
Nridge, A. B. (1965) · The Lancet · Cited by 496
White, N. J. (1996) · New England Journal of Medicine · doi:10.1056/nejm199609123351107 · Cited by 491
(1923) · Public Health · doi:10.1016/s0033-3506(23)80379-1 · Cited by 459
Fleming, A. (2001) · PubMed · Cited by 452
Lorber, B. (1997) · Clinical Infectious Diseases · doi:10.1093/clinids/24.1.1 · Cited by 420
Green, H., Paul, M., Vidal, L., & Leibovici, L. (2007) · Mayo Clinic Proceedings · doi:10.4065/82.9.1052 · Cited by 379
Finken, M., Kirschner, P., Meier, A., Wrede, A., & Böttger, E. C. (1993) · Molecular Microbiology · doi:10.1111/j.1365-2958.1993.tb01253.x · Cited by 360
Aminoglycoside Resistance in Enterococci
Chow, J. W. (2000) · Clinical Infectious Diseases · doi:10.1086/313949 · Cited by 332
Role of individual drugs in the chemotherapy of tuberculosis.
Mitchison, D. A. (2000) · PubMed · Cited by 319
Schatz, A., Bugie, E., Waksman, S. A., Hanssen, A. D., Patel, R., & Osmon, D. R. (2005) · Clinical Orthopaedics and Related Research · doi:10.1097/01.blo.0000175887.98112.fe · Cited by 305
The structure of cephalosporin C
Abraham, E. P., & Newton, G. G. F. (1961) · Biochemical Journal · doi:10.1042/bj0790377 · Cited by 296
PARA-AMINOSALICYLIC ACID IN THE TREATMENT OF TUBERCULOSIS
Lehmann, J. (1946) · The Lancet · doi:10.1016/s0140-6736(46)91185-3 · Cited by 295
Antibiotic Resistance in Streptococcus pneumoniae
Tomasz, A. (1997) · Clinical Infectious Diseases · doi:10.1093/clinids/24.supplement_1.s85 · Cited by 264
Peabody, J. W., & Seabury, J. H. (1960) · The American Journal of Medicine · doi:10.1016/0002-9343(60)90226-6 · Cited by 257
Schatz, A., & Waksman, S. A. (1944) · Experimental Biology and Medicine · doi:10.3181/00379727-57-14769 · Cited by 251
A Comparison of Ceftriaxone and Cefuroxime for the Treatment of Bacterial Meningitis in Children
Schaad, U. B., Suter, S., Gianella-Borradori, A., Pfenninger, J., Auckenthaler, R., Bernath, O., Cheseaux, J.-J., & Wedgwood, J. (1990) · New England Journal of Medicine · doi:10.1056/nejm199001183220301 · Cited by 242
Finkelstein, R., Rabino, G., Mashiah, T., Bar-El, Y., Adler, Z., Kertzman, V., Cohen, O., & Milo, S. (2002) · The Journal of Thoracic and Cardiovascular Surgery · doi:10.1067/mtc.2002.119698 · Cited by 240
Cure of duodenal ulcer after eradication of Helicobacter pylori
George, L. L., Borody, T. J., Andrews, P., Devine, M., Moore‐Jones, D., Walton, M., & Brandi, S. (1990) · Medical Journal of Australia · doi:10.5694/j.1326-5377.1990.tb136833.x · Cited by 239
Streptomycin and Alternative Agents for the Treatment of Tularemia: Review of the Literature
Enderlin, G., Morales, L., Jacobs, R. F., & Cross, J. T. (1994) · Clinical Infectious Diseases · doi:10.1093/clinids/19.1.42 · Cited by 234
Cytomegalovirus: The Monster in the Closet?
Baughman, R. P. (1997) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.156.1.ed08-97 · Cited by 233
Schwartz, R. S. (2004) · New England Journal of Medicine · doi:10.1056/nejmp048021 · Cited by 221
Oates, J. A., Wood, A. J. J., Donowitz, G. R., & Mandell, G. L. (1988) · New England Journal of Medicine · doi:10.1056/nejm198802253180806 · Cited by 208
Epidemiology of Group B Streptococcal Disease
Schuchat, A., & Wenger, J. D. (1994) · Epidemiologic Reviews · doi:10.1093/oxfordjournals.epirev.a036159 · Cited by 205
Sklar, S. H. (1975) · PubMed · Cited by 196
Tobramycin: A Review of its Antibacterial and Pharmacokinetic Properties and Therapeutic Use
Brogden, R. N., Pinder, R. M., Sawyer, P. R., Speight, T. M., & Avery, G. S. (1976) · Drugs · doi:10.2165/00003495-197612030-00002 · Cited by 195
Zhanel, G. G., Karlowsky, J. A., Harding, G. K. M., Carrie, A., Mazzulli, T., Low, D. E., The Canadian Urinary Isolate Study Group, & Hoban, D. J. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.4.1089-1092.2000 · Cited by 190
Antibiotics for sore throat (Review)
Mar, C. D., Glasziou, P., & Spinks, A. B. (2006) · e-publications@bond (Bond University) · Cited by 188
Gleckman, R., Blagg, N., & Joubert, D. W. (1981) · Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/j.1875-9114.1981.tb03548.x · Cited by 167
Wright, A. J. (1999) · Mayo Clinic Proceedings · doi:10.4065/74.3.290 · Cited by 167
Oates, J. A., Wood, A. J. J., Donowitz, G. R., & Mandell, G. L. (1988) · New England Journal of Medicine · doi:10.1056/nejm198802183180706 · Cited by 153
Deeks, S. L., Palacio, R., Ruvinsky, R., Kertesz, D. A., Hortal, M., Rossi, A., Spika, J. S., Fábio, J. L. D., & The Streptococcus pneumoniae Working Group (1999) · PEDIATRICS · doi:10.1542/peds.103.2.409 · Cited by 149
Jarvis, W. R., Schlosser, J., Chinn, R., Tweeten, S., & Jackson, M. M. (2007) · American Journal of Infection Control · doi:10.1016/j.ajic.2007.10.009 · Cited by 144
Cefepime: a reappraisal in an era of increasing antimicrobial resistance
Endimiani, A., Pérez, F., & Bonomo, R. A. (2008) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.6.6.805 · Cited by 137
Degradation, structure and some derivatives of cephalosporin N
Newton, G. G. F., & Abraham, E. P. (1954) · Biochemical Journal · doi:10.1042/bj0580103 · Cited by 132
A Practical Guide to the Treatment of Complicated Skin and Soft Tissue Infections
Fung, H. B., Chang, J. Y., & Kuczynski, S. (2003) · Drugs · doi:10.2165/00003495-200363140-00003 · Cited by 131
D’Elios, M. M., Amedei, A., Manghetti, M., Costa, F., Baldari, C. T., Quazi, A. S., Telford, J. L., Romagnani, S., & Prete, G. D. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70395-1 · Cited by 111
Zhanel, G. G., Lam, A., Schweizer, F., et al. (2008) · American Journal of Clinical Dermatology · doi:10.2165/00128071-200809040-00004 · Cited by 91
Miyake, C. Y., Gauvreau, K., Tani, L. Y., Sundel, R. P., & Newburger, J. W. (2007) · PEDIATRICS · doi:10.1542/peds.2006-3606 · Cited by 87
Antimicrobial resistance among enterococci
Herman, D. J., & Gerding, D. N. (1991) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.35.1.1 · Cited by 77
New light on the history of penicillin
Hare, R. (1982) · Medical History · doi:10.1017/s0025727300040758 · Cited by 73
Changing Susceptibility of Meningococci to Antimicrobial Agents
Eickhoff, T. C., Finland, M., & Wilcox, C. (1965) · New England Journal of Medicine · doi:10.1056/nejm196502252720804 · Cited by 72
Beta-lactamase inhibitors: agents to overcome bacterial resistance.
Maiti, S. N., Phillips, O. A., Micetich, R. G., & Livermore, D. M. (1998) · PubMed · Cited by 69
Richmond, S. M. H. (1988) · Clinical Infectious Diseases · doi:10.1093/clinids/10.4.677 · Cited by 68
β-Lactamase Inhibitors: Agents to Overcome Bacterial Resistance
Maiti, S. N., Phillips, O. A., Micetich, R. G., & Livermore, D. M. (1998) · Current Medicinal Chemistry · doi:10.2174/0929867305666220319110127 · Cited by 67
Further observations on penicillin. 1941.
Abraham, E. P., Chain, E. B., Cm, F., Florey, H. W., Ad, G., HEATLEY, N. G., & Ma, J. (1992) · PubMed · Cited by 62
THE TREATMENT OF EARLY SYPHILIS WITH PENICILLIN: A PRELIMINARY REPORT OF 1,418 CASES
MOORE, J. E. (1944) · JAMA · doi:10.1001/jama.1944.02850370005002 · Cited by 56
Penicillin Treatment of Early Syphilis: II
Mahoney, J. F. (1984) · JAMA · doi:10.1001/jama.1984.03340390059032 · Cited by 56
Everard Napier, L. (1951) · PubMed · Cited by 56
The First Use of Penicillin in the United States
Grossman, C. M. (2008) · Annals of Internal Medicine · doi:10.7326/0003-4819-149-2-200807150-00009 · Cited by 54
Antibiotic susceptibility of group A streptococci: a 6-year follow-up study
Betriú, C., Sánchez, A., Gomez, M., Cruceyra, A., & Picazo, J. J. (1993) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.37.8.1717 · Cited by 47
DiRienzo, A. G., van der Horst, C., Finkelstein, D. M., Frame, P. T., Bozzette, S. A., & Tashima, K. T. (2002) · AIDS Research and Human Retroviruses · doi:10.1089/08892220252779629 · Cited by 47
Brogden, R. N., Speight, T. M., & Avery, G. S. (1975) · Drugs · doi:10.2165/00003495-197509020-00002 · Cited by 47
Dowling, H. F. (1961) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt196125572 · Cited by 46
6-APA and the development of the β-lactam antibiotics
Rolinson, G. N. (1979) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/5.1.7 · Cited by 44
New Epidemiology for Postoperative Nosocomial Infections
Wallace, W. C., Cinat, M. E., Nastanski, F., Gornick, W. B., & Wilson, S. E. (2000) · The American Surgeon · doi:10.1177/000313480006600917 · Cited by 43
UREIDOPENICILLINS AND BETA-LACTAM/BETA-LACTAMASE INHIBITOR COMBINATIONS
Bush, L. M., & Johnson, C. C. (2000) · Infectious Disease Clinics of North America · doi:10.1016/s0891-5520(05)70255-5 · Cited by 38
PEARSON, R. D., & HEWLETT, E. L. (1987) · Annals of Internal Medicine · doi:10.7326/0003-4819-106-5-714 · Cited by 37
Kärpänoja, P., Nyberg, S. T., Bergman, M., Voipio, T., Paakkari, P., Huovinen, P., & Sarkkinen, H. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01118-07 · Cited by 35
The first clinical trial of streptomycin in human tuberculosis.
Pfuetze, K. H., Pyle, M. M., Hinshaw, H. C., & Feldman, W. H. (1955) · PubMed · doi:10.1164/artpd.1955.71.5.752 · Cited by 31
Alary, M., Joly, J. R., Mondor, M., Moutquin, J., Boucher, M., Fortier, A. M., Pinault, J.-J., Paris, G., Carrier, S., Chamberland, H., et al. (1994) · The Lancet · doi:10.1016/s0140-6736(94)90288-7 · Cited by 25
Deal, E. N., Micek, S. T., Reichley, R. M., & Ritchie, D. J. (2009) · Clinical Therapeutics · doi:10.1016/j.clinthera.2009.02.015 · Cited by 15
Enterococcal endocarditis: duration and mode of treatment.
Tompsett, R. R., & Berman, W. (1978) · PubMed Central · Cited by 14
Mahoney, J. F. (1984) · JAMA · doi:10.1001/jama.251.15.2005 · Cited by 12
Cited by
Stemming the Superbug Tide: Just A Few Dollars More
OECD (2018) · OECD Health Policy Studies · doi:10.1787/9789264307599-en · Cited by 748
Carvacrol and thymol: strong antimicrobial agents against resistant isolates
Memar, M. Y., Raei, P., Alizadeh, N., Akbari Aghdam, M., & Kafil, H. S. (2017) · Reviews in Medical Microbiology · doi:10.1097/mrm.0000000000000100 · Cited by 264
Arsenic Toxicity: Molecular Targets and Therapeutic Agents
Nurchi, V. M., Buha Djordjevic, A., Crisponi, G., Alexander, J., Bjørklund, G., & Aaseth, J. (2020) · Biomolecules · doi:10.3390/biom10020235 · Cited by 260
Antimicrobial and Antibiofilm Peptides
Di Somma, A., Moretta, A., Canè, C., Cirillo, A., & Duilio, A. (2020) · Biomolecules · doi:10.3390/biom10040652 · Cited by 258
Metadata
- Authors
- Zaffiri, L., Gardner, J., & Toledo-Pereyra, L. H.
- Venue
- Journal of Investigative Surgery
- Publisher
- Informa UK Limited
- Published
- 2012-03-22
- Volume
- 25
- Issue
- 2
- Pages
- 67-77
- ISSN
- 0894-1939 (ISSN-L)
- 1521-0553
- OpenAlex
- W2142517920
- Cited by
- 260
- References
- 86
- FWCI
- 6.01
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.